Case Study - Crystal Pharmatech Co., Ltd.

Blog Technical Insight Case Study Whitepaper Presentation

Case Study

Pediatric Formulation Excellence: Developing a Mini-tablet with a Flexible Dosing Regime

Ensuring precise dosing for pediatric populations is a significant hurdle in drug development. At Crystal Pharmatech, we specialize in overcoming these complexities through our "Molecule-to-Medicine" (Mol2Med) integrated services.

Formulation Development | Pediatric Formulation | Mini-tablet |



Small Molecule

First-Time-Right 3-STEP Approach Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Analytical Research and Quality Control First-Time-Right Formulation Development Clinical and Commercial Manufacturing Clinical Supply

Crystal Bio Solutions

Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)

Crystal NAX

DNA Synthesis RNA Synthesis LNP Formulation Services Analytical & Characterization Services Early-Phase Manufacturing Catalogue Products

Platforms

Solid-State, Crystallization & Preformulation Technical Platforms for Oral Dosage Forms

Quick Links

Highlights News Events Knowledge Hub Webinar Series

 bd_global@crystalpharmatech.com  (925) 558-5040



U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566

Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1

China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Floor 1, Bldg. 3, 68 Chunpu Road, Suzhou Industrial Park, Suzhou, China 215123

Subscribe to be the first to get the updates!

Sitemap